Article: Swiss pharma and life science company Lonza has completed its acquisition of transfection technology specialist amaxa, which is located in Koln, Germany, and Gaithersburg, Maryland, US. Amaxa's 160 employees will be integrated into Lonza.(Business digest)(acquisitions)(Brief article)

Article: Life sciences company Lonza has completed the ...
Cosmetics International;  February 23, 2007 ;     483 words ...LIFE SCIENCES company Lonza has completed the acquisition of the Research Bioproducts business and the Microbial Biopharmaceutical business of US company Cambrex ...

Article: Swiss life science company Lonza is acquiring ...
Chemistry and Industry;  June 23, 2008 ;     700+ words ...Swiss life science company Lonza is acquiring transfection technology specialist Amax, including its operations in Koln, Germany, and Gaithersburg, Maryland ...

Article: Swiss life science company Lonza has signed a new ...
Chemistry and Industry;  August 11, 2008 ;     700+ words ...Swiss life science company Lonza has signed a new strategic partnership with Novartis for the joint development and manufacture of Novartis' biologics as an extension ...

Article: Swiss fine chemicals and biotech company Lonza has ...
Chemistry and Industry;  September 5, 2005 ;     700+ words ...Swiss fine chemicals and biotech company Lonza has formed a joint venture with Asian investment management company, Bio*One Capital to establish a contract manufacturing facility ...

Article: Jeanne Thoma has taken over as head of performance chemicals at ...
Cosmetics International;  July 20, 2007 ;     296 words ...JEANNE THOMA has taken over as head of performance chemicals at Swiss company Lonza. Thoma is now based in the US state of New Jersey.

Article: Lonza buys Cambrex businesses.(Executive Briefing: News, Trends & ...
Instrument Business Outlook;  October 31, 2006 ;     700+ words ... ... East Rutherford, NJ 10/24/06--Contract manufacturing company Lonza Group has agreed to purchase Cambrex's Biopharma and Bioproducts ... in the first quarter of 2007. As a contract manufacturing company, Lonza enters the laboratory products business from a different ...

Article: Cambrex to sell 2 bio businesses for $460M
The Record (Bergen County, NJ);  October 25, 2006 ;     588 words ... ... biopharma segments — to the Swiss life-sciences company Lonza Group for $460 million. The two units accounted for 42 ... Rutherford * Cambrex plans to sell two units to the Swiss company Lonza Group for $460 million: Biopharma: $42 million annual ...